Germany
Japan
United Kingdom
China
USD 1,236.00
2 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, G (HLA-G), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Autoimmunity
View as table Download
USD 1,007.00
2 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, E (HLA-E), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,007.00
2 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, A (HLA-A), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IL6 (mGFP-tagged) - Human interleukin 6 (interferon, beta 2) (IL6), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,007.00
2 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, B (HLA-B), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IL1RAPL2 (mGFP-tagged) - Human interleukin 1 receptor accessory protein-like 2 (IL1RAPL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,290.00
2 Weeks
Lenti ORF particles, ESR2 (mGFP-tagged) - Human estrogen receptor 2 (ER beta) (ESR2), transcript variant a, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,007.00
2 Weeks
Lenti ORF particles, HLA (mGFP-tagged) - Human major histocompatibility complex, class I, C (HLA-C), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,000.00
2 Weeks
Lenti ORF particles, IL1B (mGFP-tagged) - Human interleukin 1, beta (IL1B), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,108.00
2 Weeks
Lenti ORF particles, IL18RAP (mGFP-tagged) - Human interleukin 18 receptor accessory protein (IL18RAP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 850.00
2 Weeks
Lenti ORF particles, IL36G (mGFP-tagged) - Human interleukin 1 family, member 9 (IL1F9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TOLLIP (mGFP-tagged) - Human toll interacting protein (TOLLIP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TMED1 (mGFP-tagged) - Human transmembrane emp24 protein transport domain containing 1 (TMED1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RFX3 (mGFP-tagged) - Human regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CRIP1 (mGFP-tagged) - Human cysteine-rich protein 1 (intestinal) (CRIP1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Species
- Human
Vectors
- pLenti-C-mGFP-P2A-Puro
Mutants
- No
Filter by
Target Symbol
- HFE (18)
- IL1RAP (12)
- IL37 (10)
- CASPASE 1 (9)
- ESTROGEN RECEPTOR 1 (8)
- IL1RA (8)
- CD130 (6)
- CSRP1 (6)
- ESTROGEN RECEPTOR BETA (6)
- HLAF (6)
- SIGIRR (6)
- AGBL5 (4)
- CCNL2 (4)
- CCPG1 (4)
- CP110 (4)
- CSRP2BP (4)
- CSRP3 (4)
- ENTPD6 (4)
- G0 PROTEIN ALPHA (4)
- IL1 RECEPTOR II (4)
- IL1F10 (4)
- IL36 BETA (4)
- IL36RN (4)
- IL6R (4)
- RFX2 (4)
- RFX3 (4)
- RFX4 (4)
- RFX5 (4)
- ST2 (4)
- STK19 (4)
- AGBL1 (2)
- AGBL2 (2)
- AGBL3 (2)
- AGBL4 (2)
- AGTPBP1 (2)
- C REACTIVE PROTEIN (2)
- CCDC115 (2)
- CEBP BETA (2)
- CEBPD (2)
- CEBPE (2)
- CRIP1 (2)
- CRIP2 (2)
- CRIP3 (2)
- CRYGD (2)
- CSRP2 (2)
- GRANZYME H (2)
- GRP75 (2)
- HA1 (2)
- HCP5 (2)
- HLA (2)
- HLA DM (2)
- HLA DMB (2)
- HLA DOB (2)
- HLA DP (2)
- HLA-DOA (2)
- HLA-DPB1 (2)
- HLA-DQA2 (2)
- HLA-DQB1 (2)
- HLA-DQB2 (2)
- HLA-DRA (2)
- HLA-DRB1 (2)
- HLA-DRB3 (2)
- HLA-DRB4 (2)
- HLA-DRB5 (2)
- HLAA (2)
- HLAB (2)
- HLAC (2)
- HLADQA1 (2)
- HLAE (2)
- HLAG (2)
- HMHB1 (2)
- IL1 ALPHA (2)
- IL1 BETA (2)
- IL1 RECEPTOR I (2)
- IL18 (2)
- IL18R BETA (2)
- IL18R1 (2)
- IL1RAPL1 (2)
- IL1RAPL2 (2)
- IL1RL2 (2)
- IL33 (2)
- IL36 ALPHA (2)
- IL36 GAMMA (2)
- IL6 (2)
- KIAA0020 (2)
- MYOSIN 1G (2)
- RAB3IL1 (2)
- RED (2)
- RFX1 (2)
- TMED1 (2)
- TNF ALPHA (2)
- TOLLIP (2)
- CASP1 (1)
Lentivirus
Tags
Mammalian Cell Selection
Families
Pathways
- Graft-versus-host disease (52)
- Type I diabetes mellitus (50)
- Antigen processing and presentation (48)
- Allograft rejection (46)
- Autoimmune thyroid disease (44)
- Cell adhesion molecules (CAMs) (44)
- Viral myocarditis (44)
- Cytokine-cytokine receptor interaction (42)
- Asthma (30)
- Systemic lupus erythematosus (30)
- Hematopoietic cell lineage (28)
- Apoptosis (20)
- Cytosolic DNA-sensing pathway (18)
- NOD-like receptor signaling pathway (18)
- Endocytosis (16)
- Amyotrophic lateral sclerosis (ALS) (12)
- Jak-STAT signaling pathway (12)
- MAPK signaling pathway (12)
- Natural killer cell mediated cytotoxicity (12)
- Toll-like receptor signaling pathway (8)
- Prion diseases (6)
- Alzheimer's disease (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- Long-term depression (4)
- Melanogenesis (4)
- Primary immunodeficiency (4)
- Purine metabolism (4)
- Pyrimidine metabolism (4)
- Adipocytokine signaling pathway (2)
- Dilated cardiomyopathy (2)
- Fc epsilon RI signaling pathway (2)
- Pathways in cancer (2)
- RIG-I-like receptor signaling pathway (2)
- RNA degradation (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Type II diabetes mellitus (2)